Close
APE 2026

Vetter’s Peter Soelkner featured on the “Molecule to Market” podcast

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Renewed Collaboration Between NHS & ABPI...

The Welsh NHS Confederation and the Association of the...

Latest Developments in Health and Care...

As 2025 draws to a close, it is time...

NHS Providers and NHS Confederation all...

NHS Providers and NHS Confederation went on to confirm...

Endo Announces Peyronie’s Disease Presentation at...

Endo, a wholly-owned subsidiary of Mallinckrodt plc, announced today...

Peter Soelkner featured on the “Molecule to Market” podcast

Peter Soelkner, one of the managing directors at Vetter, recently sat down with Raman Sehgal of the “Molecule to Market” podcast to share his personal background, the history of Vetter, and the ambitious goals the company is striving towards today.

Listen to the episode in your podcast player:

Latest stories

Related stories

Renewed Collaboration Between NHS & ABPI for Better Outcomes

The Welsh NHS Confederation and the Association of the...

NHS Providers and NHS Confederation all Set to Merge

NHS Providers and NHS Confederation went on to confirm...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »